Patents by Inventor Elliott Grossbard

Elliott Grossbard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMBINATION THERAPY WITH SYK KINASE INHIBITOR
    Publication number: 20090088371
    Abstract: The invention encompasses methods of increasing platelet levels in a patient having or at risk for immune thrombocytopenia comprising co-administering a Syk kinase inhibitor and a thrombopoietin receptor agonist, and methods of treating thrombocytopenia comprising co-administering a Syk kinase inhibitor and a thrombopoietin receptor agonist to a patient in need thereof, as well as pharmaceutical compositions for use in these methods.
    Type: Application
    Filed: August 27, 2008
    Publication date: April 2, 2009
    Inventor: Elliott Grossbard
  • Methods for Treating Renal Tumors Using 2, 4-Pyrimidinediamine Drug and Prodrug Compounds
    Publication number: 20090048214
    Abstract: The present disclosure provides methods for the inhibiting proliferation of tumor cells, and methods for treating solid tumor cancers in a subject by administration of 2,4-pyrimidinediamine compounds.
    Type: Application
    Filed: November 15, 2007
    Publication date: February 19, 2009
    Applicant: RIGEL PHARMACEUTICALS, INC
    Inventors: Yasumichi Hitoshi, Elliott Grossbard, Ankush Argade, Rajinder Singh, Hui Li, David Carroll, Susan Catalano
  • Methods of Treating Cell Proliferative Disorders
    Publication number: 20090012045
    Abstract: The present disclosure provides methods for the treatment of cell proliferative disorders by administration of a RET kinase inhibitor. Cell proliferative disorders treatable by the methods include, thyroid tumors.
    Type: Application
    Filed: June 26, 2008
    Publication date: January 8, 2009
    Applicant: RIGEL PHARMACEUTICALS, INC.
    Inventors: Yasumichi Hitoshi, Elliott Grossbard, Ankush Argade, Rajinder Singh
  • Methods of treating cell proliferative disorders
    Publication number: 20060276459
    Abstract: The present disclosure provides methods for the treatment of cell proliferative disorders by administration of a Syk kinase or Syk/Flt-3 kinase inhibitor. Cell proliferative disorders treatable by the methods include, hematopoietic neoplasms and virally associated tumors. The compounds are also directed to therapeutic or prophylactic inhibition of tumor metastasis.
    Type: Application
    Filed: April 18, 2006
    Publication date: December 7, 2006
    Applicant: Rigel Pharmaceuticals, Inc.
    Inventors: Esteban Masuda, Donald Payan, Elliott Grossbard